{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:52:38Z","timestamp":1793170358721,"version":"4.5.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:00:00Z","timestamp":1372723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1038\/nrgastro.2013.107","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T06:27:31Z","timestamp":1372746451000},"page":"553-562","source":"Crossref","is-referenced-by-count":857,"title":["Epidemiology and natural history of HCV infection"],"prefix":"10.1038","volume":"10","author":[{"given":"Behzad","family":"Hajarizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,2]]},"reference":[{"key":"BFnrgastro2013107_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-0031-1297922","volume":"31","author":"J Grebely","year":"2011","unstructured":"Grebely, J. & Dore, G. J. What is killing people with hepatitis C virus infection? Semin. Liver Dis. 31, 331\u2013339 (2011).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2013107_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5694\/mja11.11531","volume":"196","author":"GJ Dore","year":"2012","unstructured":"Dore, G. J. The changing therapeutic landscape for hepatitis C. Med. J. Aust. 196, 629\u2013632 (2012).","journal-title":"Med. J. Aust."},{"key":"BFnrgastro2013107_CR3","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/S0140-6736(10)61497-3","volume":"376","author":"DL Thomas","year":"2010","unstructured":"Thomas, D. L. Curing hepatitis C with pills: A step toward global control. Lancet 376, 1441\u20131442 (2010).","journal-title":"Lancet"},{"key":"BFnrgastro2013107_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy, D. The global burden of hepatitis C. Liver Int. 29, 74\u201381 (2009).","journal-title":"Liver Int."},{"key":"BFnrgastro2013107_CR5","doi-asserted-by":"crossref","unstructured":"The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 44, 20\u201329 (2004).","DOI":"10.1177\/0091270003258669"},{"key":"BFnrgastro2013107_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy, D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 17, 107\u2013115 (2011).","journal-title":"Clin. Microbiol. Infect."},{"key":"BFnrgastro2013107_CR7","unstructured":"World Health Organization. Hepatitis C\u2013global prevalence (update). Weekly Epidemiological Record 49, 425\u2013427 (1999)."},{"key":"BFnrgastro2013107_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jmv.20343","volume":"76","author":"E Nerrienet","year":"2005","unstructured":"Nerrienet, E. et al. Hepatitis C virus infection in Cameroon: A cohort-effect. J. Med. Virol. 76, 208\u2013214 (2005).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2893.2011.01576.x","volume":"19","author":"J Guerra","year":"2012","unstructured":"Guerra, J., Garenne, M., Mohamed, M. K. & Fontanet, A. HCV burden of infection in Egypt: results from a nationwide survey. J. Viral Hepat. 19, 560\u2013567 (2012).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR10","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis surveillance\u2014United States, 2010 (updated 2012) [online] , (2012)."},{"key":"BFnrgastro2013107_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2807\/ese.13.21.18880-en","volume":"13","author":"M Rantala","year":"2008","unstructured":"Rantala, M. & van de Laar, M. J. Surveillance and epidemiology of hepatitis B and C in Europe\u2014a review. Euro Surveill. 13, 194\u2013204 (2008).","journal-title":"Euro Surveill."},{"key":"BFnrgastro2013107_CR12","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong, G. L. et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144, 705\u2013714 (2006).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2013107_CR13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/eurpub\/cks013","volume":"22","author":"HJ Vriend","year":"2012","unstructured":"Vriend, H. J. et al. Hepatitis C virus seroprevalence in the Netherlands. Eur. J. Pub. Health 22, 819\u2013821 (2012).","journal-title":"Eur. J. Pub. Health"},{"key":"BFnrgastro2013107_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1080\/00365520310004542","volume":"38","author":"O Dalgard","year":"2003","unstructured":"Dalgard, O., Jeansson, S., Skaug, K., Raknerud, N. & Bell, H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand. J. Gastroenterol. 38, 864\u2013870 (2003).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2013107_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/eurpub\/ckr083","volume":"22","author":"RJ Harris","year":"2012","unstructured":"Harris, R. J. et al. Hepatitis C prevalence in England remains low and varies by ethnicity: An updated evidence synthesis. Eur. J. Pub. Health 22, 187\u2013192 (2012).","journal-title":"Eur. J. Pub. Health"},{"key":"BFnrgastro2013107_CR16","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/jmv.21734","volume":"82","author":"C Meffre","year":"2010","unstructured":"Meffre, C. et al. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors. J. Med. Virol. 82, 546\u2013555 (2010).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR17","unstructured":"The Kirby Institute. HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2012 (The Kirby Institute, the University of New South Wales, 2012)."},{"key":"BFnrgastro2013107_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000076640","volume":"47","author":"J Tanaka","year":"2004","unstructured":"Tanaka, J. et al. Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995\u20132000. Intervirology 47, 32\u201340 (2004).","journal-title":"Intervirology"},{"key":"BFnrgastro2013107_CR19","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter, M. J. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 13, 2436\u20132441 (2007).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013107_CR20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199908193410802","volume":"341","author":"MJ Alter","year":"1999","unstructured":"Alter, M. J. et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341, 556\u2013562 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013107_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1478-3231.2011.02494.x","volume":"31","author":"E Chak","year":"2011","unstructured":"Chak, E., Talal, A. H., Sherman, K. E., Schiff, E. R. & Saab, S. Hepatitis C virus infection in USA: An estimate of true prevalence. Liver Int. 31, 1090\u20131101 (2011).","journal-title":"Liver Int."},{"key":"BFnrgastro2013107_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hep.510310332","volume":"31","author":"GL Armstrong","year":"2000","unstructured":"Armstrong, G. L., Alter, M. J., McQuillan, G. M. & Margolis, H. S. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States. Hepatology 31, 777\u2013782 (2000).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9343(99)00373-3","volume":"107","author":"I Williams","year":"1999","unstructured":"Williams, I. Epidemiology of hepatitis C in the United States. Am. J. Med. 107, 2\u20139 (1999).","journal-title":"Am. J. Med."},{"key":"BFnrgastro2013107_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/archinternmed.2010.511","volume":"171","author":"IT Williams","year":"2011","unstructured":"Williams, I. T., Bell, B. P., Kuhnert, W. & Alter, M. J. Incidence and transmission patterns of acute hepatitis C in the United States, 1982\u20132006. Arch. Intern. Med. 171, 242\u2013248 (2011).","journal-title":"Arch. Intern. Med."},{"key":"BFnrgastro2013107_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","volume":"91","author":"K Razali","year":"2007","unstructured":"Razali, K. et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend. 91, 228\u2013235 (2007).","journal-title":"Drug Alcohol Depend."},{"key":"BFnrgastro2013107_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","volume":"31","author":"W Sievert","year":"2011","unstructured":"Sievert, W. et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 31, 61\u201380 (2011).","journal-title":"Liver Int."},{"key":"BFnrgastro2013107_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000048270","volume":"62","author":"H Yoshizawa","year":"2002","unstructured":"Yoshizawa, H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology 62, 8\u201317 (2002).","journal-title":"Oncology"},{"key":"BFnrgastro2013107_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jhep.2004.09.023","volume":"42","author":"Y Tanaka","year":"2005","unstructured":"Tanaka, Y. et al. Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. J. Hepatol. 42, 47\u201353 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2458-9-34","volume":"9","author":"N M\u00fchlberger","year":"2009","unstructured":"M\u00fchlberger, N. et al. HCV-related burden of disease in Europe: A systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 9, 34 (2009).","journal-title":"BMC Public Health"},{"key":"BFnrgastro2013107_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jhep.2008.06.016","volume":"49","author":"L Gheorghe","year":"2008","unstructured":"Gheorghe, L., Iacob, S. & Csiki, I. E. Prevalence of hepatitis C in Romania: Different from European rates? J. Hepatol. 49, 661\u2013662 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR31","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/BF01718286","volume":"141","author":"DK Lvov","year":"1996","unstructured":"Lvov, D. K. et al. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. Arch. Virol. 141, 1613\u20131622 (1996).","journal-title":"Arch. Virol."},{"key":"BFnrgastro2013107_CR32","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/jmv.20376","volume":"76","author":"F Ansaldi","year":"2005","unstructured":"Ansaldi, F. et al. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J. Med. Virol. 76, 327\u2013332 (2005).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.annepidem.2007.05.007","volume":"17","author":"E Delarocque-Astagneau","year":"2007","unstructured":"Delarocque-Astagneau, E. et al. An incident case-control study of modes of hepatitis C virus transmission in France. Ann. Epidemiol. 17, 755\u2013762 (2007).","journal-title":"Ann. Epidemiol."},{"key":"BFnrgastro2013107_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2807\/ese.13.21.18882-en","volume":"13","author":"A Duberg","year":"2008","unstructured":"Duberg, A., Janzon, R., B\u00e4ck, E., Ekdahl, K. & Blaxhult, A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill. 13, 181\u2013185 (2008).","journal-title":"Euro Surveill."},{"key":"BFnrgastro2013107_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ije\/dym096","volume":"36","author":"L Prasad","year":"2007","unstructured":"Prasad, L. et al. Cohort profile: The Swiss Hepatitis C Cohort Study (SCCS). Int. J. Epidemiol. 36, 731\u2013737 (2007).","journal-title":"Int. J. Epidemiol."},{"key":"BFnrgastro2013107_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1478-3231.2011.02539.x","volume":"31","author":"M Cornberg","year":"2011","unstructured":"Cornberg, M. et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 31, 30\u201360 (2011).","journal-title":"Liver Int."},{"key":"BFnrgastro2013107_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/MEG.0b013e3282f479ab","volume":"20","author":"G Defossez","year":"2008","unstructured":"Defossez, G. et al. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: A comparative cross-sectional study in Poitou-Charentes region. Eur. J. Gastroenterol. Hepatol. 20, 367\u2013372 (2008).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2893.2009.01196.x","volume":"17","author":"E Delarocque-Astagneau","year":"2010","unstructured":"Delarocque-Astagneau, E. et al. The impact of the prevention programme of hepatitis C over more than a decade: The French experience. J. Viral Hepat. 17, 435\u2013443 (2010).","journal-title":"J. Viral Hepat."},{"issue":"Suppl. 1","key":"BFnrgastro2013107_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0168-8278(99)80380-8","volume":"31","author":"NV Naoumov","year":"1999","unstructured":"Naoumov, N. V. Hepatitis C virus infection in Eastern Europe. J. Hepatol. 31 (Suppl. 1), 84\u201387 (1999).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR40","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2007.07.033","volume":"48","author":"JI Esteban","year":"2008","unstructured":"Esteban, J. I., Sauleda, S. & Quer, J. The changing epidemiology of hepatitis C virus infection in Europe. J. Hepatol. 48, 148\u2013162 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR41","doi-asserted-by":"publisher","first-page":"14757","DOI":"10.1073\/pnas.1008877107","volume":"107","author":"FD Miller","year":"2010","unstructured":"Miller, F. D. & Abu-Raddad, L. J. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc. Natl Acad. Sci. 107, 14757\u201314762 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"BFnrgastro2013107_CR42","unstructured":"Centers for Disease Control and Prevention. Progress toward prevention and control of hepatitis C virus infection\u2014Egypt, 2001\u20132012. MMWR 61, 545\u2013549 (2012)."},{"key":"BFnrgastro2013107_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","volume":"355","author":"C Frank","year":"2000","unstructured":"Frank, C. et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355, 887\u2013891 (2000).","journal-title":"Lancet"},{"key":"BFnrgastro2013107_CR44","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/gut.2009.194266","volume":"59","author":"A Paez Jimenez","year":"2010","unstructured":"Paez Jimenez, A. et al. HCV iatrogenic and intrafamilial transmission in Greater Cairo, Egypt. Gut 59, 1554\u20131560 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2013107_CR45","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/gut.2007.140681","volume":"57","author":"S Plancoulaine","year":"2008","unstructured":"Plancoulaine, S. et al. Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection. Gut 57, 1268\u20131274 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2013107_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/hep.20811","volume":"42","author":"MK Mohamed","year":"2005","unstructured":"Mohamed, M. K. et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology 42, 683\u2013687 (2005).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijid.2008.06.019","volume":"13","author":"SA Ali","year":"2009","unstructured":"Ali, S. A., Donahue, R. M. J., Qureshi, H. & Vermund, S. H. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int. J. Infect. Dis. 13, 9\u201319 (2009).","journal-title":"Int. J. Infect. Dis."},{"key":"BFnrgastro2013107_CR48","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3748\/wjg.15.5647","volume":"15","author":"Y Waheed","year":"2009","unstructured":"Waheed, Y., Shafi, T., Safi, S. Z. & Qadri, I. Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J. Gastroenterol. 15, 5647\u20135653 (2009).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013107_CR49","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.ijid.2009.11.032","volume":"14","author":"S Merat","year":"2010","unstructured":"Merat, S. et al. Seroprevalence of hepatitis C virus: The first population-based study from Iran. Int. J. Infect. Dis. 14, e113\u2013e116 (2010).","journal-title":"Int. J. Infect. Dis."},{"key":"BFnrgastro2013107_CR50","first-page":"47","volume":"4","author":"SM Alavian","year":"2009","unstructured":"Alavian, S. M. Hepatitis C infection in Iran; A review article. Iranian J. Clin. Infect. Dis. 4, 47\u201359 (2009).","journal-title":"Iranian J. Clin. Infect. Dis."},{"key":"BFnrgastro2013107_CR51","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0928-4346(96)82012-3","volume":"5","author":"G-L Xia","year":"1996","unstructured":"Xia, G.-L. et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int. Hepatol. Comm. 5, 62\u201373 (1996).","journal-title":"Int. Hepatol. Comm."},{"key":"BFnrgastro2013107_CR52","doi-asserted-by":"publisher","first-page":"e8467","DOI":"10.1371\/journal.pone.0008467","volume":"4","author":"J Lu","year":"2009","unstructured":"Lu, J. et al. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS ONE 4, e8467 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013107_CR53","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3201\/eid1511.090263","volume":"15","author":"F Liu","year":"2009","unstructured":"Liu, F. et al. Hepatitis C seroprevalence and associated risk factors, Anyang, China. Emerg. Infect. Dis. 15, 1819\u20131822 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"BFnrgastro2013107_CR54","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5812\/hepatmon.5123","volume":"12","author":"Z Yan","year":"2012","unstructured":"Yan, Z. et al. Changing pattern of clinical epidemiology on hepatitis C virus infection in Southwest China. Hepatitis Monthly 12, 196\u2013204 (2012).","journal-title":"Hepatitis Monthly"},{"key":"BFnrgastro2013107_CR55","doi-asserted-by":"publisher","first-page":"e7193","DOI":"10.1371\/journal.pone.0007193","volume":"4","author":"A Paez Jimenez","year":"2009","unstructured":"Paez Jimenez, A. et al. Injection drug use is a risk factor for HCV infection in urban Egypt. PLoS ONE 4, e7193 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013107_CR56","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1537-2995.2004.04073.x","volume":"44","author":"L Thaikruea","year":"2004","unstructured":"Thaikruea, L. et al. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 44, 1433\u20131440 (2004).","journal-title":"Transfusion"},{"key":"BFnrgastro2013107_CR57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.35.1.201-207.1997","volume":"35","author":"T Ohno","year":"1997","unstructured":"Ohno, T. et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J. Clin. Microbiol. 35, 201\u2013207 (1997).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2013107_CR58","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JCM.32.4.884-892.1994","volume":"32","author":"P Simmonds","year":"1994","unstructured":"Simmonds, P. et al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey. J. Clin. Microbiol. 32, 884\u2013892 (1994).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2013107_CR59","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1440-1746.1998.tb00761.x","volume":"13","author":"S Kaba","year":"1998","unstructured":"Kaba, S. et al. Molecular epidemiology of hepatitis C in Australia. J. Gastroenterol. Hepatol. 13, 914\u2013920 (1998).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcv.2008.02.001","volume":"42","author":"S Chlabicz","year":"2008","unstructured":"Chlabicz, S. et al. Changing HCV genotypes distribution in Poland\u2014Relation to source and time of infection. J. Clin. Virol. 42, 156\u2013159 (2008).","journal-title":"J. Clin. Virol."},{"key":"BFnrgastro2013107_CR61","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/jmv.20828","volume":"79","author":"T Tallo","year":"2007","unstructured":"Tallo, T. et al. Genetic characterization of hepatitis C virus strains in Estonia: Fluctuations in the predominating subtype with time. J. Med. Virol. 79, 374\u2013382 (2007).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2893.2005.00649.x","volume":"13","author":"A Katsoulidou","year":"2006","unstructured":"Katsoulidou, A. et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J. Viral Hepat. 13, 19\u201327 (2006).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1365-2893.2005.00605.x","volume":"12","author":"C Payan","year":"2005","unstructured":"Payan, C. et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J. Viral Hepat. 12, 405\u2013413 (2005).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR64","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/01.meg.0000219103.40435.8d","volume":"18","author":"J Delwaide","year":"2006","unstructured":"Delwaide, J. et al. HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin. Eur. J. Gastroenterol. Hepatol. 18, 707\u2013712 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR65","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/jmv.20706","volume":"78","author":"N Fern\u00e1ndez-Arc\u00e1s","year":"2006","unstructured":"Fern\u00e1ndez-Arc\u00e1s, N. et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): Phylogenetic and epidemiological analyses. J. Med. Virol. 78, 1429\u20131435 (2006).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR66","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/hep.22127","volume":"47","author":"SM Kamal","year":"2008","unstructured":"Kamal, S. M. & Nasser, I. A. Hepatitis C genotype 4: What we know and what we don't yet know. Hepatology 47, 1371\u20131383 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR67","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1096-9071(199905)58:1<44::AID-JMV6>3.0.CO;2-U","volume":"58","author":"OA Shobokshi","year":"1999","unstructured":"Shobokshi, O. A., Serebour, F. E., Skakni, L., Al-Saffy, Y. H. & Ahdal, M. N. Hepatitis C genotypes and subtypes in Saudi Arabia. J. Med. Virol. 58, 44\u201348 (1999).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1017\/S095026880800054X","volume":"137","author":"N Antaki","year":"2009","unstructured":"Antaki, N. et al. The unexpected discovery of a focus of hepatitis C virus genotype 5 in a Syrian province. Epidemiol. Infect. 137, 79\u201384 (2009).","journal-title":"Epidemiol. Infect."},{"key":"BFnrgastro2013107_CR69","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0168-8278(96)80194-2","volume":"24","author":"DG Murphy","year":"1996","unstructured":"Murphy, D. G. et al. Biological and clinicopathological features associated with hepatitis C virus type 5 infections. J. Hepatol. 24, 109\u2013113 (1996).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR70","first-page":"153","volume":"27","author":"AP Duc","year":"2009","unstructured":"Duc, A. P. et al. High prevalence of hepatitis C virus genotype 6 in Vietnam. Asian Pac. J. Allergy Immunol. 27, 153\u2013160 (2009).","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"BFnrgastro2013107_CR71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jmv.21430","volume":"81","author":"CSY Li","year":"2009","unstructured":"Li, C. S. Y., Chan, P. K. S. & Tang, J. W. Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong. J. Med. Virol. 81, 628\u2013633 (2009).","journal-title":"J. Med. Virol."},{"key":"BFnrgastro2013107_CR72","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095\u20132128 (2012).","journal-title":"Lancet"},{"key":"BFnrgastro2013107_CR73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F. & Bell, B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45, 529\u2013538 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-2000-9506","volume":"20","author":"A Wasley","year":"2000","unstructured":"Wasley, A. & Alter, M. J. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin. Liver Dis. 20, 1\u201316 (2000).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2013107_CR75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.mrrev.2008.01.005","volume":"659","author":"WA Anwar","year":"2008","unstructured":"Anwar, W. A., Khaled, H. M., Amra, H. A., El-Nezami, H. & Loffredo, C. A. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: Possibilities for prevention. Mutat. Res. 659, 176\u2013184 (2008).","journal-title":"Mutat. Res."},{"key":"BFnrgastro2013107_CR76","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jhep.2005.08.008","volume":"44","author":"S Deuffic-Burban","year":"2006","unstructured":"Deuffic-Burban, S., Mohamed, M. K., Larouze, B., Carrat, F. & Valleron, A.-J. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J. Hepatol. 44, 455\u2013461 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR77","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/CEJ.0b013e328345f99e","volume":"20","author":"A Arf\u00e8","year":"2011","unstructured":"Arf\u00e8, A. et al. Cancer mortality trend analysis in Italy, 1970\u20132007. Eur. J. Cancer Prevent. 20, 364\u2013374 (2011).","journal-title":"Eur. J. Cancer Prevent."},{"key":"BFnrgastro2013107_CR78","doi-asserted-by":"publisher","first-page":"820","DOI":"10.7326\/0003-4819-148-11-200806030-00004","volume":"148","author":"H Tanaka","year":"2008","unstructured":"Tanaka, H. et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann. Intern. Med. 148, 820\u2013826 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2013107_CR79","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","volume":"138","author":"GL Davis","year":"2010","unstructured":"Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T. & Jennings, L. W. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, 513\u2013521 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR80","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1753-6405.2007.00121.x","volume":"31","author":"J Amin","year":"2007","unstructured":"Amin, J. et al. Liver cancer and hepatitis B and C in New South Wales, 1990\u20132002: A linkage study. Aust. NZ J. Public Health 31, 475\u2013482 (2007).","journal-title":"Aust. NZ J. Public Health"},{"key":"BFnrgastro2013107_CR81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0962280208094697","volume":"18","author":"S Deuffic-Burban","year":"2009","unstructured":"Deuffic-Burban, S., Mathurin, P. & Valleron, A. J. Modelling the past, current and future HCV burden in France: Detailed analysis and perspectives. Stat. Methods Med. Res. 18, 233\u2013252 (2009).","journal-title":"Stat. Methods Med. Res."},{"key":"BFnrgastro2013107_CR82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00042737-200201000-00006","volume":"14","author":"M Sagmeister","year":"2002","unstructured":"Sagmeister, M., Renner, E. L., Mullhaupt, B. & Wong, J. B. Simulation of hepatitis C based on a mandatory reporting system. Eur. J. Gastroenterol. Hepatol. 14, 25\u201334 (2002).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/jhep.2001.22112","volume":"33","author":"JR Orland","year":"2001","unstructured":"Orland, J. R., Wright, T. L. & Cooper, S. Acute hepatitis C. Hepatology 33, 321\u2013327 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR84","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/428578","volume":"40","author":"AL Cox","year":"2005","unstructured":"Cox, A. L. et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin. Infect. Dis. 40, 951\u2013958 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2013107_CR85","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1128\/JCM.01229-07","volume":"46","author":"K Page-Shafer","year":"2008","unstructured":"Page-Shafer, K. et al. Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J. Clin. Microbiol. 46, 499\u2013506 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"BFnrgastro2013107_CR86","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/j.1537-2995.2005.04390.x","volume":"45","author":"SA Glynn","year":"2005","unstructured":"Glynn, S. A. et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 45, 994\u20131002 (2005).","journal-title":"Transfusion"},{"key":"BFnrgastro2013107_CR87","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","volume":"57","author":"B Hajarizadeh","year":"2012","unstructured":"Hajarizadeh, B., Grebely, J. & Dore, G. J. Case definitions for acute hepatitis C virus infection: A systematic review. J. Hepatol. 57, 1349\u20131360 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR88","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1002\/hep.25575","volume":"55","author":"L Liu","year":"2012","unstructured":"Liu, L., Fisher, B. E., Thomas, D. L., Cox, A. L. & Ray, S. C. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology 55, 1684\u20131691 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR89","first-page":"150","volume-title":"The 8th Australasian Viral Hepatitis Conference","author":"B Hajarizadeh","year":"2012","unstructured":"Hajarizadeh, B. et al. in The 8th Australasian Viral Hepatitis Conference 150 (Australasian Society for HIV Medicine, Auckland, New Zealand, 2012)."},{"key":"BFnrgastro2013107_CR90","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1086\/605561","volume":"49","author":"BH McGovern","year":"2009","unstructured":"McGovern, B. H. et al. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin. Infect. Dis. 49, 1051\u20131060 (2009).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2013107_CR91","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/hep.26263","volume":"57","author":"J Grebely","year":"2013","unstructured":"Grebely, J. et al. Plasma interferon-\u03b3-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology 57, 2124\u20132134 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR92","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.20742","volume":"42","author":"JW Mosley","year":"2005","unstructured":"Mosley, J. W. et al. Viral and host factors in early hepatitis C virus infection. Hepatology 42, 86\u201392 (2005).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR93","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef, J. M., Kaldor, J. M. & Dore, G. J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Viral Hepat. 13, 34\u201341 (2006).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR94","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1086\/605947","volume":"200","author":"K Page","year":"2009","unstructured":"Page, K. et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J. Infect. Dis. 200, 1216\u20131226 (2009).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2013107_CR95","doi-asserted-by":"publisher","first-page":"22741","DOI":"10.1074\/jbc.R109.099556","volume":"285","author":"SM Lemon","year":"2010","unstructured":"Lemon, S. M. Induction and evasion of innate antiviral responses by hepatitis C virus. J. Biol. Chem. 285, 22741\u201322747 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro2013107_CR96","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1172\/JCI39133","volume":"119","author":"B Rehermann","year":"2009","unstructured":"Rehermann, B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119, 1745\u20131754 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2013107_CR97","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/75063","volume":"6","author":"A Takaki","year":"2000","unstructured":"Takaki, A. et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6, 578\u2013582 (2000).","journal-title":"Nat. Med."},{"key":"BFnrgastro2013107_CR98","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1053\/j.gastro.2010.07.005","volume":"139","author":"HL Tillmann","year":"2010","unstructured":"Tillmann, H. L. et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139, 1586\u20131592 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR99","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/hep.23850","volume":"52","author":"J Grebely","year":"2010","unstructured":"Grebely, J. et al. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 52, 1216\u20131224 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR100","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798\u2013801 (2009).","journal-title":"Nature"},{"key":"BFnrgastro2013107_CR101","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","volume":"131","author":"T Marcello","year":"2006","unstructured":"Marcello, T. et al. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131, 1887\u20131898 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR102","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1128\/JVI.73.4.2938-2946.1999","volume":"73","author":"SC Ray","year":"1999","unstructured":"Ray, S. C. et al. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J. Virol. 73, 2938\u20132946 (1999).","journal-title":"J. Virol."},{"key":"BFnrgastro2013107_CR103","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2893.2006.00795.x","volume":"14","author":"HE Harris","year":"2007","unstructured":"Harris, H. E. et al. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? J. Viral Hepat. 14, 213\u2013220 (2007).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR104","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","volume":"349","author":"T Poynard","year":"1997","unstructured":"Poynard, T., Bedossa, P. & Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349, 825\u2013832 (1997).","journal-title":"Lancet"},{"key":"BFnrgastro2013107_CR105","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.1572-0241.2002.05555.x","volume":"97","author":"TE Wiley","year":"2002","unstructured":"Wiley, T. E., Brown, J. & Chan, J. Hepatitis C infection in African Americans: Its natural history and histological progression. Am. J. Gastroenterol. 97, 700\u2013706 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013107_CR106","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1182\/blood-2001-12-0192","volume":"99","author":"E Minola","year":"2002","unstructured":"Minola, E. et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99, 4588\u20134591 (2002).","journal-title":"Blood"},{"key":"BFnrgastro2013107_CR107","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1086\/321909","volume":"33","author":"CS Graham","year":"2001","unstructured":"Graham, C. S. et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin. Infect. Dis. 33, 562\u2013569 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2013107_CR108","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0168-8278(03)00470-7","volume":"39","author":"GB Gaeta","year":"2003","unstructured":"Gaeta, G. B. et al. Epidemiological and clinical burden of chronic hepatitis B virus\/hepatitis C virus infection. A multicenter Italian study. J. Hepatol. 39, 1036\u20131041 (2003).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR109","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0168-8278(03)00456-2","volume":"39","author":"V Ratziu","year":"2003","unstructured":"Ratziu, V., Munteanu, M., Charlotte, F., Bonyhay, L. & Poynard, T. Fibrogenic impact of high serum glucose in chronic hepatitis C. J. Hepatol. 39, 1049\u20131055 (2003).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR110","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","volume":"125","author":"JM Hui","year":"2003","unstructured":"Hui, J. M. et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 125, 1695\u20131704 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR111","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.510290401","volume":"29","author":"LF Hourigan","year":"1999","unstructured":"Hourigan, L. F. et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29, 1215\u20131219 (1999).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR112","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","volume":"130","author":"G Leandro","year":"2006","unstructured":"Leandro, G. et al. relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130, 1636\u20131642 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR113","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1542-3565(05)00407-6","volume":"3","author":"SJ Hutchinson","year":"2005","unstructured":"Hutchinson, S. J., Bird, S. M. & Goldberg, D. J. Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clin. Gastroenterol. Hepatol. 3, 1150\u20131159 (2005).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/hep.20733","volume":"42","author":"C H\u00e9zode","year":"2005","unstructured":"H\u00e9zode, C. et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 42, 63\u201371 (2005).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR115","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1136\/gut.52.1.126","volume":"52","author":"C H\u00e9zode","year":"2003","unstructured":"H\u00e9zode, C. et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 52, 126\u2013129 (2003).","journal-title":"Gut"},{"key":"BFnrgastro2013107_CR116","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/jhep.2001.25385","volume":"34","author":"F Pessione","year":"2001","unstructured":"Pessione, F. et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 34, 121\u2013125 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR117","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","volume":"51","author":"PY Bochud","year":"2009","unstructured":"Bochud, P. Y. et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J. Hepatol. 51, 655\u2013666 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR118","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0168-8278(00)00097-0","volume":"34","author":"T Poynard","year":"2001","unstructured":"Poynard, T. et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J. Hepatol. 34, 730\u2013739 (2001).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR119","doi-asserted-by":"crossref","first-page":"s35","DOI":"10.1002\/hep.1840360706","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff, L. B. Natural history of chronic hepatitis C. Hepatology 36, s35\u2013s46 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR120","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/hep.22375","volume":"48","author":"HH Thein","year":"2008","unstructured":"Thein, H. H., Yi, Q., Dore, G. J. & Krahn, M. D. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression. Hepatology 48, 418\u2013431 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR121","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","volume":"22","author":"HH Thein","year":"2008","unstructured":"Thein, H. H., Yi, Q., Dore, G. J. & Krahn, M. D. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 22, 1979\u20131991 (2008).","journal-title":"AIDS"},{"key":"BFnrgastro2013107_CR122","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1053\/jhep.2001.27831","volume":"34","author":"AJ Freeman","year":"2001","unstructured":"Freeman, A. J. et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34, 809\u2013816 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR123","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR124","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich, G., Stroffolini, T., Zagni, I. & Donato, F. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127, S35\u2013S50 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013107_CR125","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cncr.10662","volume":"95","author":"H Hamada","year":"2002","unstructured":"Hamada, H. et al. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer 95, 331\u2013339 (2002).","journal-title":"Cancer"},{"key":"BFnrgastro2013107_CR126","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.22870","volume":"49","author":"R Masuzaki","year":"2009","unstructured":"Masuzaki, R. et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49, 1954\u20131961 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2013107_CR127","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/0962280208094690","volume":"18","author":"SA McDonald","year":"2009","unstructured":"McDonald, S. A. et al. A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat. Methods Med. Res. 18, 271\u2013283 (2009).","journal-title":"Stat. Methods Med. Res."},{"key":"BFnrgastro2013107_CR128","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jhep.2010.08.035","volume":"54","author":"SR Walter","year":"2011","unstructured":"Walter, S. R. et al. Trends in mortality after diagnosis of hepatitis B or C infection: 1992\u20132006. J. Hepatol. 54, 879\u2013886 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2893.2010.01279.x","volume":"18","author":"J Grebely","year":"2011","unstructured":"Grebely, J. et al. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents. J. Viral Hepat. 18, 32\u201341 (2011).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro2013107_CR130","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","volume":"105","author":"L Degenhardt","year":"2009","unstructured":"Degenhardt, L. et al. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved. Drug Alcohol Depend. 105, 9\u201315 (2009).","journal-title":"Drug Alcohol Depend."},{"key":"BFnrgastro2013107_CR131","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee, M. H. et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J. Infect. Dis. 206, 469\u2013477 (2012).","journal-title":"J. Infect. Dis."},{"key":"BFnrgastro2013107_CR132","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","volume":"297","author":"TP Giordano","year":"2007","unstructured":"Giordano, T. P. et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297, 2010\u20132017 (2007).","journal-title":"JAMA"},{"key":"BFnrgastro2013107_CR133","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10620-012-2141-4","volume":"57","author":"J Bonner","year":"2012","unstructured":"Bonner, J., Barritt, A. S., Fried, M. & Evon, D. Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health\/substance abuse issues. Dig. Dis. Sci. 57, 1469\u20131474 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2013107_CR134","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","volume":"364","author":"S Arora","year":"2011","unstructured":"Arora, S. et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N. Engl. J. Med. 364, 2199\u20132207 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013107_CR135","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cgh.2011.05.022","volume":"9","author":"D Larrey","year":"2011","unstructured":"Larrey, D. et al. Education by a nurse increases response of patients with chronic hepatitis C to therapy with peginterferon-\u03b12a and ribavirin. Clin. Gastroenterol. Hepatol. 9, 781\u2013785 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR136","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/j.1440-1746.2007.05032.x","volume":"22","author":"J Grebely","year":"2007","unstructured":"Grebely, J. et al. Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users. J. Gastroenterol. Hepatol. 22, 1519\u20131525 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR137","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","volume":"22","author":"J Grebely","year":"2010","unstructured":"Grebely, J. et al. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support. Eur. J. Gastroenterol. Hepatol. 22, 270\u2013277 (2010).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013107_CR138","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1477-7517-5-8","volume":"5","author":"J Norman","year":"2008","unstructured":"Norman, J. et al. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm. Reduction J. 5, 8 (2008).","journal-title":"Harm. Reduction J."},{"key":"BFnrgastro2013107_CR139","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.drugpo.2007.01.010","volume":"18","author":"DL Sylvestre","year":"2007","unstructured":"Sylvestre, D. L. & Zweben, J. E. Integrating HCV services for drug users: A model to improve engagement and outcomes. Int. J. Drug Policy 18, 406\u2013410 (2007).","journal-title":"Int. J. Drug Policy"},{"key":"BFnrgastro2013107_CR140","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/gut.2006.099150","volume":"56","author":"AA Butt","year":"2007","unstructured":"Butt, A. A. et al. Rate and predictors of treatment prescription for hepatitis C. Gut 56, 385\u2013389 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2013107_CR141","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2008.04.021","volume":"49","author":"B Lettmeier","year":"2008","unstructured":"Lettmeier, B. et al. Market uptake of new antiviral drugs for the treatment of hepatitis C. J. Hepatol. 49, 528\u2013536 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2013107_CR142","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/hep.23220","volume":"50","author":"ML Volk","year":"2009","unstructured":"Volk, M. L., Tocco, R., Saini, S. & Lok, A. S. F. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 50, 1750\u20131755 (2009).","journal-title":"Hepatology"}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.107","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:47:44Z","timestamp":1746002864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,2]]},"references-count":142,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["BFnrgastro2013107"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.107","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,2]]}}}